Macclesfield, United Kingdom

Craig Johnstone

USPTO Granted Patents = 22 



Average Co-Inventor Count = 3.3

ph-index = 13

Forward Citations = 483(Granted Patents)


Location History:

  • Cheshire, GB (2008 - 2009)
  • Macclesfield, GB (1998 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Craig Johnstone - A Pioneer in Pharmaceutical Patents

Introduction

Craig Johnstone, based in Macclesfield, GB, is a notable inventor with an impressive portfolio of 22 patents. His innovative work primarily focuses on biochemistry and pharmaceutical compounds, significantly contributing to advancements in therapeutic agents.

Latest Patents

Among Craig's latest patented inventions are cutting-edge compounds that serve vital functions in treating various conditions. One of his patents discloses 1,3,4-oxadiazole derivatives as DGAT1 inhibitors. These compounds inhibit acetyl CoA (acetyl coenzyme A): diacylglycerol acyltransferase (DGAT1) activity, showcasing a novel approach to target metabolic pathways. Another significant invention is the phenyl thiophene carboxamide compounds, which function as inhibitors of the enzyme IKK-2. This patent elaborates on the preparation processes and pharmaceutical compositions relevant to these compounds, highlighting their potential in therapeutic applications.

Career Highlights

Craig has had a distinguished career, notably working with leading pharmaceutical companies such as AstraZeneca and Zeneca Limited. His experiences at these organizations have not only shaped his technical expertise but have also allowed him to contribute substantially to the field of pharmaceutical development.

Collaborations

Throughout his career, Craig Johnstone has collaborated with esteemed colleagues, including Andrew Peter Thomas and Laurent Francois Andre Hennequin. These partnerships have played a pivotal role in fostering innovation and driving transformative research initiatives in the industry.

Conclusion

Craig Johnstone stands out as a remarkable inventor whose contributions to pharmaceutical patents have had a lasting impact. His commitment to innovation, coupled with his collaborative efforts, continues to inspire advancements in therapeutic solutions that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…